These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 16135412

  • 1. Lack of enterocyte iron accumulation in the ferroportin disease.
    Corradini E, Montosi G, Ferrara F, Caleffi A, Pignatti E, Barelli S, Garuti C, Pietrangelo A.
    Blood Cells Mol Dis; 2005; 35(3):315-8. PubMed ID: 16135412
    [Abstract] [Full Text] [Related]

  • 2. Ferroportin disease: pathogenesis, diagnosis and treatment.
    Pietrangelo A.
    Haematologica; 2017 Dec; 102(12):1972-1984. PubMed ID: 29101207
    [Abstract] [Full Text] [Related]

  • 3. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
    Mayr R, Griffiths WJ, Hermann M, McFarlane I, Halsall DJ, Finkenstedt A, Douds A, Davies SE, Janecke AR, Vogel W, Cox TM, Zoller H.
    Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
    [Abstract] [Full Text] [Related]

  • 4. Targeting PKCα alleviates iron overload in diabetes and hemochromatosis through the inhibition of ferroportin.
    Banerjee S, Lu S, Jain A, Wang I, Tao H, Srinivasan S, Nemeth E, He P.
    Blood; 2024 Sep 26; 144(13):1433-1444. PubMed ID: 38861671
    [Abstract] [Full Text] [Related]

  • 5. Iron overload due to mutations in ferroportin.
    De Domenico I, Ward DM, Musci G, Kaplan J.
    Haematologica; 2006 Jan 26; 91(1):92-5. PubMed ID: 16434376
    [Abstract] [Full Text] [Related]

  • 6. Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload.
    Jouanolle AM, Douabin-Gicquel V, Halimi C, Loréal O, Fergelot P, Delacour T, de Lajarte-Thirouard AS, Turlin B, Le Gall JY, Cadet E, Rochette J, David V, Brissot P.
    J Hepatol; 2003 Aug 26; 39(2):286-9. PubMed ID: 12873829
    [Abstract] [Full Text] [Related]

  • 7. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
    Koyama C, Wakusawa S, Hayashi H, Ueno T, Suzuki R, Yano M, Saito H, Okazaki T.
    Intern Med; 2005 Sep 26; 44(9):990-3. PubMed ID: 16258219
    [Abstract] [Full Text] [Related]

  • 8. The role of hepcidin and ferroportin in iron absorption.
    Oates PS.
    Histol Histopathol; 2007 Jul 26; 22(7):791-804. PubMed ID: 17455153
    [Abstract] [Full Text] [Related]

  • 9. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
    Détivaud L, Island ML, Jouanolle AM, Ropert M, Bardou-Jacquet E, Le Lan C, Mosser A, Leroyer P, Deugnier Y, David V, Brissot P, Loréal O.
    Hum Mutat; 2013 Nov 26; 34(11):1529-36. PubMed ID: 23943237
    [Abstract] [Full Text] [Related]

  • 10. Molecular and clinical correlates in iron overload associated with mutations in ferroportin.
    De Domenico I, McVey Ward D, Nemeth E, Ganz T, Corradini E, Ferrara F, Musci G, Pietrangelo A, Kaplan J.
    Haematologica; 2006 Aug 26; 91(8):1092-5. PubMed ID: 16885049
    [Abstract] [Full Text] [Related]

  • 11. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.
    Altamura S, Kessler R, Gröne HJ, Gretz N, Hentze MW, Galy B, Muckenthaler MU.
    Cell Metab; 2014 Aug 05; 20(2):359-67. PubMed ID: 25100063
    [Abstract] [Full Text] [Related]

  • 12. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H, McFarlane I, Theurl I, Stadlmann S, Nemeth E, Oxley D, Ganz T, Halsall DJ, Cox TM, Vogel W.
    Hepatology; 2005 Aug 05; 42(2):466-72. PubMed ID: 15986403
    [Abstract] [Full Text] [Related]

  • 13. The ferroportin disease.
    Pietrangelo A.
    Blood Cells Mol Dis; 2004 Aug 05; 32(1):131-8. PubMed ID: 14757427
    [Abstract] [Full Text] [Related]

  • 14. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
    Mayr R, Janecke AR, Schranz M, Griffiths WJ, Vogel W, Pietrangelo A, Zoller H.
    J Hepatol; 2010 Nov 05; 53(5):941-9. PubMed ID: 20691492
    [Abstract] [Full Text] [Related]

  • 15. Effect of ferroportin polymorphism on iron homeostasis and infection.
    Kasvosve I.
    Clin Chim Acta; 2013 Feb 01; 416():20-5. PubMed ID: 23178444
    [Abstract] [Full Text] [Related]

  • 16. G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective.
    McDonald CJ, Wallace DF, Ostini L, Bell SJ, Demediuk B, Subramaniam VN.
    J Hepatol; 2011 Mar 01; 54(3):538-44. PubMed ID: 21094556
    [Abstract] [Full Text] [Related]

  • 17. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro.
    Moreno-Carralero MI, Muñoz-Muñoz JA, Cuadrado-Grande N, López-Rodríguez R, José Hernández-Alfaro M, del-Castillo-Rueda A, Enríquez-de-Salamanca R, Méndez M, Morán-Jiménez MJ.
    Am J Hematol; 2014 Jul 01; 89(7):689-94. PubMed ID: 24644245
    [Abstract] [Full Text] [Related]

  • 18. RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation.
    Jiang L, Wang J, Wang K, Wang H, Wu Q, Yang C, Yu Y, Ni P, Zhong Y, Song Z, Xie E, Hu R, Min J, Wang F.
    Blood; 2021 Aug 26; 138(8):689-705. PubMed ID: 33895792
    [Abstract] [Full Text] [Related]

  • 19. The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.
    Zohn IE, De Domenico I, Pollock A, Ward DM, Goodman JF, Liang X, Sanchez AJ, Niswander L, Kaplan J.
    Blood; 2007 May 15; 109(10):4174-80. PubMed ID: 17289807
    [Abstract] [Full Text] [Related]

  • 20. Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.
    Zhang DL, Ghosh MC, Ollivierre H, Li Y, Rouault TA.
    Blood; 2018 Nov 08; 132(19):2078-2087. PubMed ID: 30213870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.